These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5374544)

  • 21. Comparison of perphenazine and P-5227 in chronic schizophrenics: clinical and EEG effects.
    Holden JM; Itil TM; Keskiner A
    J Clin Pharmacol J New Drugs; 1969; 9(3):163-75. PubMed ID: 5255181
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of attention/information processing impairment of tardive dyskinesia and neuroleptics in chronic schizophrenics.
    Spohn HE; Coyne L
    Brain Cogn; 1993 Sep; 23(1):28-39. PubMed ID: 8105820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with delusional and bizarre thinking.
    Anstett RE; Poole SR; Wood L
    J Fam Pract; 1984 Apr; 18(4):591-9. PubMed ID: 6707592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of drug withdrawal on tardive dyskinesia.
    Crane GE; Ruiz P; Kernohan WJ; Wilson W; Royalty N
    Act Nerv Super (Praha); 1969; 11(1):30-5. PubMed ID: 5770140
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuropsychological performance in schizophrenics with histories of substance abuse.
    Scott ML; Cole JK; McKay SE; Golden CJ; MacInnes WD
    Int J Neurosci; 1982 Dec; 17(4):209-13. PubMed ID: 7169291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship of the brief psychiatric rating scale to neuropsychological deficits in phenothiazine-treated schizophrenics.
    Golden CJ; Carpenter B; Wilkening G; Ruedrich S; Chu CC; Graber B
    Psychopharmacol Bull; 1983; 19(3):513-7. PubMed ID: 6138799
    [No Abstract]   [Full Text] [Related]  

  • 27. Clozapine in patients with chronic schizophrenia: serum level, EEG and memory performance.
    Adler G; Grieshaber S; Faude V; Thebaldi B; Dressing H
    Pharmacopsychiatry; 2002 Sep; 35(5):190-4. PubMed ID: 12237790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some effects of mesoridazine (TPS-23) on chronic psychiatric patients.
    Douglas KW; Hindley JP; Kerin MT
    Dis Nerv Syst; 1967 Feb; 28(2):113-7. PubMed ID: 6021590
    [No Abstract]   [Full Text] [Related]  

  • 29. [Bodyweight in inpatients with schizophrenia].
    Wetterling T; Pest S; Müssigbrodt H; Weber B
    Psychiatr Prax; 2004 Jul; 31(5):250-4. PubMed ID: 15243875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dynamics and treatment of the tendency to enchronization of schizophrenic psychoses].
    López-Ibor Aliño JM
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(2):377-88. PubMed ID: 4147379
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pregnancy infections in mothers of chronic schizophrenic patients. The significance of differential nosology].
    Stöber G; Franzek E; Beckmann H
    Nervenarzt; 1994 Mar; 65(3):175-82. PubMed ID: 8177358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Polygraphic picture of night sleep of schizophrenics during maintenance dosage with phenothiazine derivatives].
    Kiljan A; Rzepecki J; Kubacki A; Wilczak H; Jus K; Jus A
    Psychiatr Pol; 1968; 2(2):189-95. PubMed ID: 5678237
    [No Abstract]   [Full Text] [Related]  

  • 33. [Schizophrenia and chronic states of delirium].
    Jarret R; Moutet HP
    Soins Pathol Trop; 1982; (36):16-9. PubMed ID: 6923533
    [No Abstract]   [Full Text] [Related]  

  • 34. Urinary excretion of catecholamines and their metabolites in chronic schizophrenics treated with oxypertine and chlorpromazine.
    Kiriike N; Uete T; Motomura K; Enomoto M; Murata K
    Biol Psychiatry; 1984 Mar; 19(3):417-22. PubMed ID: 6144330
    [No Abstract]   [Full Text] [Related]  

  • 35. High and low dose thiothixene treatment in chronic schizophrenia.
    Gardos G; Orzack MH; Finn G; Cole JO
    Dis Nerv Syst; 1974 Feb; 35(2):53-8. PubMed ID: 17894041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of phenothiazine withdrawal on proverb interpretation by chronic schizophrenics.
    Chapman LJ; Cameron R; Cocke JG; Pritchett T
    J Abnorm Psychol; 1975 Feb; 84(1):24-9. PubMed ID: 234133
    [No Abstract]   [Full Text] [Related]  

  • 37. EEG findings in central nervous system disorders due to internal diseases with special consideration of the comatous states.
    Penin H
    Wien Z Nervenheilkd Grenzgeb; 1971; 29(1):123. PubMed ID: 4329946
    [No Abstract]   [Full Text] [Related]  

  • 38. Piperacetazine (Quide): a controlled evaluation of the elixir in chronic schizophrenic patients.
    Gallant DM; Bishop MP
    Curr Ther Res Clin Exp; 1970 Jun; 12(6):387-9. PubMed ID: 4987346
    [No Abstract]   [Full Text] [Related]  

  • 39. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
    Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The long-term course of spike and wave complexes in the waking EEG of chronic schizophrenics.
    Matsuura M; Yoshino M; Onda H; Kojima T
    Clin Electroencephalogr; 1996 Oct; 27(4):202-9. PubMed ID: 9465284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.